Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER IMMUNOTHERAPY

Optimizing CARs for ocular delivery

Nature Cancer volume 1, pages 939–940 (2020)Cite this article

Subjects

Effective methods for treating retinoblastoma while preserving vision are an unmet clinical need. Subretinal delivery of a hydrogel containing T cells that secrete the cytokine IL-15 and express a chimeric antigen receptor directed at the ganglioside protein GD2 completely controls retinoblastoma in immunocompromised mice, with no obvious damage to the surrounding retina.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Treatment of retinoblastoma with GD2 CAR T cells.

References

  1. Abramson, D. H., Francis, J. H. & Gobin, Y. P. Int. Ophthalmol. Clin. 59, 87–94 (2019).

    Article  Google Scholar 

  2. Wang, K. et al. Nat. Cancer https://doi.org/10.1038/s43018-020-00119-y (2020).

  3. Chen, Y. et al. Clin. Cancer Res. 25, 2915–2924 (2019).

    Article  CAS  Google Scholar 

  4. Hegde, M. et al. Mol. Ther. 21, 2087–2101 (2013).

    Article  CAS  Google Scholar 

  5. Seigel, G. M., Sharma, S., Hackam, A. S. & Shah, D. K. Tumour Biol. 37, 6135–6142 (2016).

    Article  CAS  Google Scholar 

  6. Andersch, L. et al. BMC Cancer 19, 895 (2019).

    Article  Google Scholar 

  7. Long, A. H. et al. Cancer Immunol. Res. 4, 869–880 (2016).

    Article  CAS  Google Scholar 

  8. Piña, Y. et al. Invest. Ophthalmol. Vis. Sci. 51, 2671–2677 (2010).

    Article  Google Scholar 

  9. Raguraman, R. et al. Ocul. Oncol. Pathol. 5, 85–93 (2019).

    Article  Google Scholar 

  10. Gargett, T. et al. Mol. Ther. 24, 1135–1149 (2016).

    Article  CAS  Google Scholar 

  11. Pule, M. A. et al. Nat. Med. 14, 1264–1270 (2008).

    Article  CAS  Google Scholar 

  12. Mount, C. W. et al. Nat. Med. 24, 572–579 (2018).

    Article  CAS  Google Scholar 

  13. Louis, C. U. et al. Blood 118, 6050–6056 (2011).

    Article  CAS  Google Scholar 

  14. Keino, H., Horie, S. & Sugita, S. J. Immunol. Res. 2018, 1679197 (2018).

    Article  Google Scholar 

  15. Depil, S., Duchateau, P., Grupp, S. A., Mufti, G. & Poirot, L. Nat. Rev. Drug Discov. 19, 185–199 (2020).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

    Anandani Nellan & Terry J. Fry

  2. Center for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO, USA

    Anandani Nellan & Terry J. Fry

Authors
  1. Anandani Nellan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Terry J. Fry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Terry J. Fry.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nellan, A., Fry, T.J. Optimizing CARs for ocular delivery. Nat Cancer 1, 939–940 (2020). https://doi.org/10.1038/s43018-020-00127-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-020-00127-y

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing